Trial NCT00363883

View at ClinicalTrials.gov 
Org. Study IDs: NCI-2012-02844
Secondary IDs: 6879 N01CM62209 NCI-2012-02844 P30CA033572 PHII-61

Last trial update was posted on 2015-02-13

MeSH Interventions

Vorinostat

MeSH Conditions

Carcinoma Carcinoma, Transitional Cell Kidney Neoplasms Recurrence Ureteral Neoplasms Urinary Bladder Neoplasms

Other Conditions

Localized Transitional Cell Cancer of the Renal Pelvis and Ureter Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter Regional Transitional Cell Cancer of the Renal Pelvis and Ureter Transitional Cell Carcinoma of the Bladder

Stopping Reasons

Trial stopped early for futility

Limitations And Caveats

Study was terminated early after the first stage of a two-stage design, allowing for early termination for discouraging results.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID